Status:
COMPLETED
Antiepileptic Drug Carbamazepine in Treatment of Bronchial Asthma
Lead Sponsor:
Centre of Chinese Medicine, Georgia
Collaborating Sponsors:
Rea Rehabilitation Centre, Georgia
Conditions:
Bronchial Asthma
Eligibility:
All Genders
16+ years
Phase:
PHASE4
Brief Summary
The purpose of this study was evaluation the efficacy of antiepileptic drug carbamazepine in the treatment of mild-to-severe bronchial asthma.
Detailed Description
Effective therapy of asthma still remains quite serious problem. According current opinion of leading specialists, asthma is an inflammatory disorder. But asthma also is a paroxysmal disorder: many sp...
Eligibility Criteria
Inclusion
- Out patients
- Bronchial asthma has been known at least for 1 year
- Absence of long-term remissions of asthma (lasting more than 1 month)
- Poorly controlled asthma, due to various reasons
- Non-smokers
Exclusion
- Presence of concomitant acute or chronic severe diseases
- Abnormal baseline haematology, blood chemistry or urinalysis
- Allergy or adverse reactions to investigational drug
- Age younger than 16 years old
- Long-term history of smoking
- Pregnancy or lactating
Key Trial Info
Start Date :
August 1 1999
Trial Type :
INTERVENTIONAL
End Date :
April 1 2000
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT00207428
Start Date
August 1 1999
End Date
April 1 2000
Last Update
May 16 2006
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.